Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intermittent parathyroid hormone therapy to increase bone formation.

Thierry Thomas1

  • 1Inserm E0366, Service de Rhumatologie, CHU de Saint-Etienne, France. thierry.thomas@univ-st-etienne.fr

Joint Bone Spine
|March 28, 2006
PubMed
Summary

Intermittent parathyroid hormone (PTH) therapy shows promise for osteoporosis treatment. This therapy primarily promotes bone anabolism, leading to increased bone mass and strength, unlike antiresorptive drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Combination of Percutaneous Cryoablation, Screw Fixation, and Cementoplasty for Painful Pelvic Bone Metastases: A Supportive Care Approach Improving Pain, Mobility, and Quality of Life.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Early upper and lower limbs bone microarchitecture alterations evaluated by HR-PQCT after stroke with hemiplegia.

Joint bone spine·2025
Same author

Bone Health Following Lifestyle-Induced Weight Loss in Individuals With Overweight/Obesity: A Narrative Review.

Obesity (Silver Spring, Md.)·2025
Same author

Combination Therapy Using Embolization, Gelified Alcohol Sclerotherapy, and Vertebroplasty to Treat Aggressive Vertebral Hemangioma: Technique and Initial Results.

Journal of vascular and interventional radiology : JVIR·2025
Same author

Percutaneous Pelvic Cementoplasty With or Without Screw Fixation in Patients Aged 70 Years and Over: Safety and Clinical Outcomes.

Journal of vascular and interventional radiology : JVIR·2025

Area of Science:

  • Bone biology and osteoporosis treatment.
  • Endocrinology and metabolic bone diseases.

Background:

  • Osteoporosis treatment aims to improve bone mass and reduce fracture risk.
  • Parathyroid hormone (PTH) has complex effects on bone, influencing both resorption and formation.

Purpose of the Study:

  • To review evidence supporting intermittent PTH therapy as a treatment for osteoporosis.
  • To elucidate the predominant anabolic effects of intermittent PTH on bone.

Main Methods:

  • Review of clinical, cell culture, and histological studies on PTH therapy.
  • Analysis of biochemical and bone mineral density responses in clinical trials.

Main Results:

  • Intermittent PTH therapy demonstrates predominantly anabolic effects on bone.

Related Experiment Videos

  • Improvements in trabecular and cortical microarchitecture and biomechanical strength were observed.
  • Significant increases in spinal bone mineral density were achieved early in treatment.

    • Conclusions:

    • Intermittent PTH therapy is a valid treatment option for osteoporosis.
    • The therapy's anabolic action enhances bone quality and strength.
    • Its effects on microarchitecture differ from antiresorptive agents.